All posts tagged
How did this Biotech seal a €1B Deal with AstraZeneca? The CEO Explains
It’s Global Rare Disease Day! What Cures is Biotech Cooking Up?
UPDATE: J&J and Actelion settle on a price, R&D assets will be spun out
How is Biotech responding to Patient Advocacy in Rare Disease?
New British Partnership set to Cure Rare Diseases with Gene Therapy
Interview with Two Key People of the Fight Against Lupus
UK Cannabis Drug in Phase III Trial Success for Rare Epilepsy
Our Top 5 Articles on Biotech & Rare Disease
Exploiting the Power of NGS to Diagnose Rare Diseases
It’s Rare Disease Day 2016: Here are 7 Indications which Biotech is Fighting
2011-2015: What a Fantastic 5 Years for European Biotech
Rare Diseases: Still a ‘Blue Ocean’ for Biotechs?
Labiotech UG, All Rights Reserved -
Send this to friend